Does CABOZANTINIB Cause Off label use? 190 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Off label use have been filed in association with CABOZANTINIB. This represents 5.0% of all adverse event reports for CABOZANTINIB.
190
Reports of Off label use with CABOZANTINIB
5.0%
of all CABOZANTINIB reports
71
Deaths
76
Hospitalizations
How Dangerous Is Off label use From CABOZANTINIB?
Of the 190 reports, 71 (37.4%) resulted in death, 76 (40.0%) required hospitalization, and 11 (5.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB. However, 190 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB Cause?
Diarrhoea (404)
Fatigue (263)
Malignant neoplasm progression (238)
Nausea (215)
Decreased appetite (191)
Hypertension (165)
Pyrexia (162)
Vomiting (157)
Asthenia (153)
Death (153)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CABOZANTINIB Alternatives Have Lower Off label use Risk?
CABOZANTINIB vs CABOZANTINIB S-MALATE
CABOZANTINIB vs CAFFEINE
CABOZANTINIB vs CALASPARGASE PEGOL
CABOZANTINIB vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB vs CALCIFEDIOL